(1,552,238) Profit / (loss) after income tax for DNA Vaccines 2014 up from (1,327,299) in 2013
Travel and seminars med div= (266,469) CC= (1,056,414) DNA div=(10,073) plant=(1,548) corporate=(214,689) total= (1,549,193)
There, not a lot like you portrayed
- Forums
- ASX - By Stock
- AVR
- good bad or indifferent
good bad or indifferent, page-55
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.00 |
Change
0.090(0.50%) |
Mkt cap ! $344.2M |
Open | High | Low | Value | Volume |
$18.00 | $18.00 | $18.00 | $16.63K | 924 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 92 | $17.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.14 | 942 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 681 | 18.000 |
1 | 94 | 17.810 |
2 | 451 | 17.800 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
Price($) | Vol. | No. |
---|---|---|
18.190 | 36 | 1 |
18.220 | 27 | 1 |
18.230 | 36 | 1 |
18.240 | 500 | 1 |
18.300 | 150 | 1 |
Last trade - 10.19am 16/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online